Skip to content
← Back to this collection

PUBLICATIONS · 38577760

A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2024 Jun
First author
Yoneda A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Yoneda A
      type
      Author
    2. name
      Shichino H
      type
      Author
    3. name
      Hishiki T
      type
      Author
    4. name
      Matsumoto K
      type
      Author
    5. name
      Ohira M
      type
      Author
    6. name
      Kamijo T
      type
      Author
    7. name
      Kuroda T
      type
      Author
    8. name
      Soejima T
      type
      Author
    9. name
      Nakazawa A
      type
      Author
    10. name
      Takimoto T
      type
      Author
    11. name
      Yokota I
      type
      Author
    12. name
      Teramukai S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Yoneda A
      type
      Author
    2. name
      Shichino H
      type
      Author
    3. name
      Hishiki T
      type
      Author
    4. name
      Matsumoto K
      type
      Author
    5. name
      Ohira M
      type
      Author
    6. name
      Kamijo T
      type
      Author
    7. name
      Kuroda T
      type
      Author
    8. name
      Soejima T
      type
      Author
    9. name
      Nakazawa A
      type
      Author
    10. name
      Takimoto T
      type
      Author
    11. name
      Yokota I
      type
      Author
    12. name
      Teramukai S
      type
      Author
    bibliography ids
    1. nci-bib-429e8cb5fb6a3124f7f968f2
    book metadata
    content sha256
    3ae1d45da92e6e267ea34c96d55f2005ce932c7d86016b332e7345c1b714b2c6
    document type
    citation
    dois
    1. 10.1002/pbc.30976
    electronic publication date
    display
    2024 Apr 5
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38577760
    immutable id
    pubmed:38577760@3ae1d45da92e6e267ea34c96d55f2005ce932c7d86016b332e7345c1b714b2c6
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    6
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e30976
    volume
    71
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38577760
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      85a0b0ab998427c1a80601f37ee8777b49d4534e8e739363ee1d95581e973c12
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Jun
      precision
      month
      year
      2024
      publication types
      1. Journal Article
      2. Clinical Trial, Phase II
      3. Research Support, Non-U.S. Gov't
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38577760/
      title
      A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.

      Preserved source evidence · Not medical advice